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Synthesis of prostaglandin E allyl ester via two-component coupling process
and the conversion of the allyl ester moiety into free carboxylic acid by the reaction with
HC02H-Et3N in the presence of a palladium catalyst has been described.
The hydrolysis of methyl ester of prostaglandin E (PGE) is unavoidable step for synthesis of PGE through
two- and three-component coupling processes. This step is usually carried out by using enzymes or
microorganisms, because the ~-hydroxy (or alkoxy) ketone moiety embeded in PGE is intolerable under the
conditions of chemical hydrolysis. I) Enzymes or microorganisms, however, are sensitive in terms of structures
of the substrate and it causes sometimes trouble for synthesis of PGE analogues, thus the development of an
efficient chemical method for conversion of the ester moiety of PGE into free carboxylic acid has been
anticipated.
Recently we have devoted our efforts to make the two-component coupling synthesis of prostaglandins
as industrially viable process.2) We have succeeded in developing highly practical method for synthesis of
Stork's intermediate (1)2a) and also have succeeded in introducing a.-side chains having ester group directly
onto 1 by using zinc-copper reagents.2b) With these results in hand we were interested in the recent report from
Tsuji's research group which described that allyl esters were converted to the 1-olefins and carboxylic acids by
the reaction of ammonium formate using a palladium catalyst, and thus the allyl group could be used as a
carboxy-protecting group. 3,4) Herein we report the synthesis of allyl ester of PGE (2) by the reaction of 1 with
the corresponding zinc-copper reagent of a.-side chain, and its conversion into PGE under the Tsuji's conditions.
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The reaction of the enone la with the copper regent 3 prepared from I-(CH2)5-COO-CH2CH=CH2 via
zinc compound in the presence of Me3SiCl5) provided the corresponding silyl enol ether in essentially
quantitative yield, which was hydrolyzed in aqueous i-PrOH-Et20 in the presence of a catalytic amount of















The conversion of the allyl ester moiety of 2a into free carboxylic acid was carried out as follows: to a
solution of aqueous HC02H (88%, 5.6 ~L, 1.13 mmol), Et3N (0.13 mL, 0.96 mmol) and Pd2(dba)3-CHCl3
(33.1 mg, 0.032 mmol, dba = dibenzylideneacetone) in THF (3.2 mL) was added n-Bu3P (31.9 ~L, 0.128
mmol) and the mixture was stirred for 15 min at room temperature. To this mixture was added a solution of 2a
(200 mg, 0.32 mmol) in THF (0.7 mL), and then the mixture was heated at 40 °c for} h. To the reaction
mixture were added brine (10 mL) and hexane (10 mL). The organic layer was separated and the aqueous layer
was extracted with hexane (5 mL). The combined organic layers were dried over MgS04, concentrated and
chromatographed on silica gel to afford the disilyl ether of roE1 (4) (172.6 mg) in 93% yield, the spectroscopic
data of which were identical with that of authentic sample.2a)
Next, we applied this chemical conversion method for the synthesis of a powerful antithrombotic
prostaglandin analogue Limaprost (Ono-Dainihon),7) since we had found that the emzymatic hydrolysis of the
methyl ester of Limaprost using porcine liver esterase was very slow and did not complete even after 5 days
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reaction. The reaction of Ib with the organocopper compound 5 afforded 68) ([a]D21 _32.9° (c 1.63, CHCI3»
in 77% yield. The reaction of 6 with HC02H-Et3N in the presence of Pd2(dba)3-CHCI3 for 2 h at 40°C
a







6 : R = TBS, R' = CH2CH=CH2
Limaprost : R = R' = H
afforded the disilyl ether of Limaprost9) ([a]D20 -35.1 0 (c 1.53, CHCI3» in 94% yield, which was in turn
converted into Limaprost in 73% yield by treatment with aqueous HF (50%) in acetonitrile. The spectroscopic
data, mp, and Rfvalue on thin layer chromatography of Limaprost thus obtained were in good agreement with
the literature ones. 10)
In conclusion, we have succeeded for the first time in conversion of the ester moiety of PGE into free
carboxylic acid by chemical method, which undoubtedly simplifies the two-component coupling synthesis of
PGs.
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